Riskpilot← Back to searchSign inGet full accessBarbora Medika AB
ABActiveOrg 5591511794Brolyckan 13General medical practice activities · NACE 8621Est. 20181 employees
Revenue 2024
SEK 51K
-72% vs 2023
EBITDA margin
151.0%
+127% vs 2023
Equity ratio
60.5%
Financial strength
Net profit 2024
SEK 115K
+5650% vs 2023
| Revenue | SEK 51K | -72% |
| EBITDA | SEK 77K | +127% |
| Net profit | SEK 115K | +5650% |
| Total assets | SEK 821K | -23% |
| Equity | SEK 497K | -15% |
| Employees | 1 | — |
Legal name
Barbora Medika AB
Org number
5591511794
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 mars 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva allmän läkarpraktik, sjuk- och hälsovård. Bolaget skall även bedriva handel med värdepapper. Bolaget skall också äga och förvalta fastigheter samt bedriva handel med fastigheter.
Address
Brolyckan 13
Email
b.kuchynkova@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 687 | 1 628 | 319 | 179 | 51 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 947 | 890 | 97 | −290 | 77 |
| Depreciation & amort. | −65 | −65 | −65 | −22 | −0 |
| EBIT | 882 | 825 | 32 | −312 | 77 |
| Net financials | — | — | — | 2 | 9 |
| Profit before tax | 672 | 639 | 32 | 10 | 146 |
| Tax | −144 | −137 | −7 | −8 | −31 |
| Net profit | 528 | 502 | 25 | 2 | 115 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 724 | 2 041 | 1 533 | 1 072 | 821 |
| Equity | 790 | 1 027 | 780 | 587 | 497 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 429 | 324 | 63 | 116 | 14 |
| Total debt | 429 | 324 | 63 | 116 | 14 |
EBITDA margin
151.0%
This company
15.8%
Market median
+856% vs market
20202024
Equity ratio
60.5%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
23.1%
This company
18.4%
Market median
+26% vs market
20202024
Net profit margin
225.5%
This company
8.1%
Market median
+2684% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-11-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Barbora Medika AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Simánek | Deputy Board Member | 0 companies |
| Barbora Simánek | Board of Directors | 0 companies |